Association of Permanent Vascular Access Dysfunction with Subsequent Risk of Cardiovascular Disease: A Population-Based Cohort Study

被引:4
作者
Hung, Tung-Wei [1 ,2 ,3 ]
Wu, Sheng-Wen [1 ,2 ,3 ]
Chiou, Jeng-Yuan [4 ]
Wang, Yu-Hsun [5 ]
Liao, Yu-Chan [3 ]
Wei, Cheng-Chung [1 ,2 ,6 ]
机构
[1] Chung Shan Med Univ, Sch Med, Taichung 402306, Taiwan
[2] Chung Shan Med Univ, Inst Med, Taichung 402306, Taiwan
[3] Chung Shan Med Univ Hosp, Dept Internal Med, Div Nephrol, Taichung 40201, Taiwan
[4] Chung Shan Med Univ, Sch Hlth Policy & Management, Inst Med, 110 Sec 1,Jianguo N Rd, Taichung 40201, Taiwan
[5] Chung Shan Med Univ Hosp, Dept Med Res, Taichung 40201, Taiwan
[6] Chung Shan Med Univ Hosp, Dept Med, Div Allergy Immunol & Rheumatol, Taichung 40201, Taiwan
关键词
permanent vascular access; arteriovenous fistula; arteriovenous grafts; dialysis; cardiovascular disease; VENOUS NEOINTIMAL HYPERPLASIA; ARTERIOVENOUS-FISTULAS; HEMODIALYSIS; OUTCOMES; FAILURE; PATENCY; PATHOPHYSIOLOGY; EPIDEMIOLOGY; MORTALITY; KIDNEY;
D O I
10.3390/jpm12040598
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
A functional permanent vascular access (VA) is required to perform a successful hemodialysis procedure. Hemodialysis VA dysfunction is a major cause of morbidity and hospitalization in the hemodialysis population. Cardiovascular disease (CVD) is the leading cause of death in patients receiving chronic hemodialysis. Information about CVD associated with hemodialysis VA dysfunction is unclear. We analyzed the association between dialysis VA dysfunction and the risk of developing CVD in hemodialysis patients. This nationwide population-based cohort study was conducted using data from the National Health Insurance Research Database in Taiwan. One million subjects were sampled from 23 million beneficiaries and data was collected from 2000 to 2013. Patients with end-stage renal disease who had received permanent VA construction and hemodialysis and were aged at least 20 years old from 2000 to 2007 were included in the study population. The primary outcome was CVD, as defined by ICD-9-CM codes 410-414 and 430-437. A total of 197 individuals with permanent VA dysfunction were selected as the test group, and 100 individuals with non-permanent VA dysfunction were selected as the control group. Compared with the control group, the adjusted hazard ratio of CVD for the VA dysfunction group was 3.05 (95% CI: 1.14-8.20). A Kaplan-Meier analysis revealed that the cumulative incidence of CVD was higher in the permanent VA dysfunction group than in the comparison group. Permanent VA dysfunction is significantly associated with an increased risk of subsequent CVD.
引用
收藏
页数:9
相关论文
共 40 条
[1]   Hemodialysis-induced cardiovascular disease [J].
Ahmadmehrabi, Shadi ;
Tang, W. H. Wilson .
SEMINARS IN DIALYSIS, 2018, 31 (03) :258-267
[2]   The effect of statin therapy on the formation of arteriovenous fistula stenoses and the rate of reoccurrence of previously treated stenoses [J].
Birch, Nathan ;
Fillaus, Jennifer ;
Florescu, Marius C. .
HEMODIALYSIS INTERNATIONAL, 2013, 17 (04) :586-593
[3]   Thrombophilia Associated with Early Post-angioplasty Thrombosis of Dialysis Vascular Access [J].
Chen, Tsung-Yan ;
Lin, Lin ;
Hsieh, Mu-Yang ;
Chen, Chiu-Hui ;
Chen, Meng-Kan ;
Wu, Chih-Cheng .
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2018, 41 (11) :1683-1690
[4]   Cardiac diseases in maintenance hemodialysis patients: Results of the HEMO Study [J].
Cheung, AK ;
Sarnak, MJ ;
Yan, GF ;
Berkoben, M ;
Heyka, R ;
Kaufman, A ;
Lewis, J ;
Rocco, M ;
Toto, R ;
Windus, D ;
Ornt, D ;
Levey, AS .
KIDNEY INTERNATIONAL, 2004, 65 (06) :2380-2389
[5]   Cardiovascular disease in dialysis patients [J].
Cozzolino, Mario ;
Mangano, Michela ;
Stucchi, Andrea ;
Ciceri, Paola ;
Conte, Ferruccio ;
Galassi, Andrea .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 :28-34
[6]   The Cardiovascular Burden in End-Stage Renal Disease [J].
Cozzolino, Mario ;
Galassi, Andrea ;
Pivari, Francesca ;
Ciceri, Paola ;
Conte, Ferruccio .
EXPANDED HEMODIALYSIS: INNOVATIVE CLINICAL APPROACH IN DIALYSIS, 2017, 191 :44-57
[7]   Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis - A randomized controlled trial [J].
Dember, Laura M. ;
Beck, Gerald J. ;
Allon, Michael ;
Delmez, James A. ;
Dixon, Bradley S. ;
Greenberg, Arthur ;
Himmelfarb, Jonathan ;
Vazquez, Miguel A. ;
Gassman, Jennifer J. ;
Greene, Tom ;
Radeva, Milena K. ;
Braden, Gregory L. ;
Ikizler, T. Alp ;
Rocco, Michael V. ;
Davidson, Ingemar J. ;
Kaufman, James S. ;
Meyers, Catherine M. ;
Kusek, John W. ;
Feldman, Harold I. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (18) :2164-2171
[8]   Clinical epidemiology of cardiovascular disease in chronic renal disease [J].
Foley, RN ;
Parfrey, PS ;
Sarnak, MJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (05) :S112-S119
[9]   Characteristics of Elderly Patients with Diabetes and End-Stage Renal Disease [J].
Goldfarb-Rumyantzev, Alexander S. ;
Rout, Preeti .
SEMINARS IN DIALYSIS, 2010, 23 (02) :185-190
[10]   Hemodialysis arteriovenous fistula patency revisited: Results of a prospective, multicenter initiative [J].
Huijbregts, Henricus J. T. ;
Bots, Michiel L. ;
Wittens, Cees H. A. ;
Schrama, Yvonne C. ;
Moll, Frans L. ;
Blankestijn, Peter J. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 3 (03) :714-719